Find a Doctor

Michael Fisher, MD

Attending physician

Associate professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Abstracts

2009

Fisher MJ. Photodynamic therapy in children with NF1 and plexiform neurofibromas [abstract].  2009 Children’s Tumor Foundation Neurofibromatosis Conference. 2009; Portland, OR. p.35.

Fisher MJ, Balcer L, Listernick R, Gutmann D, Packer R, Ferner R, et al. Retrospective analysis of NF1-associated optic glioma visual outcomes [abstract]. 2009 Children’s Tumor Foundation Neurofibromatosis Conference. 2009, Portland, OR. p.89.

Campen CJ, Fisher MJ, Belasco JB, Ichord RN. Moyamoya disease and neurofibromatosis  type 1 in children: a prospective cohort study [abstract]. International Stroke Conference. 2009. San Diego.

Awards

1992-1993, Howard Hughes Medical Institute Research Fellow
1989, Sigma Xi, The Scientific Research Society
1989, Phi Beta Kappa

Books

Chapters

2010

Fisher MJ, Rheingold SR. Oncologic emergencies. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 6th ed. Philadelphia: Lippincott, William & Wilkins; 2010.

2008

Fisher MJ, Minturn J, Armstrong G, Phillips PC. Brain tumors. In: Brodeur GM, Manno CS, editors. Requisites in pediatrics: hematology and oncology. Philadelphia: Elsevier Mosby; 2008.

Fisher MJ. Brain tumors. In: Schwartz MW, editor. The 5-minute pediatric consult. 5th ed. Philadelphia: Lippincott William & Wilkins; 2008. p. 120-21.

2006

Fisher MJ, Phillips PC. PET imaging of brain tumors. In: Charron M, editor. Practical pediatric PET imaging. New York: Springer Science + Business Media, Inc.; 2006. p. 175-219.

2005

Fisher MJ. Brain tumors. In: Schwartz MW, editor. The 5-minute pediatric consult. 4th ed. Philadelphia: Lippincott William & Wilkins; 2005. p. 194-95.

2004

Fisher MJ, Marino BS, Litman RS. Oncological diseases. In: Litman RS, editor. Pediatric anesthesia: the requisites in anesthesiology. Philadelphia: Elsevier Mosby; 2004. p. 60-7.

2003

Fisher MJ, Kramer DL, Needle M. Brain tumors. In: Schwartz MW, editor. The 5-minute pediatric consult. 3rd ed. Baltimore: Willian and Wilkins; 2003. p. 190-91.

2001

Fisher MJ, Cohen A. Normal red blood cell indices and differential diagnosis of anemia. In: Polin RA, Spitzer A, editors. Fetal and neonatal secrets. Philadelphia: Hanley and Belfus, Inc.; 2001. p. 227-29.

Editorial and Academic Positions

Editorial positions

Reviewer

Pediatric Blood & Cancer
Libertas Academica

Leadership

Memberships in professional organizations

American Academy of Pediatrics
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Pediatric Hematology-Oncology
Children's Oncology Group
CDMRP Neurofibromatosis Consortium
Pediatric Brain Tumor Consortium
Society for Neuro-Oncology

Participation in national scientific committees

2009-present, Co-chair, CDMRP Neurofibromatosis Consortium Neurofibroma Committee

2009-present, Local PI, CHOP/University of Pennsylvania site, CDMRP Neurofibromatosis Consortium

2008-present, Member, CDMRP Neurofibromatosis Consortium Steering Committee

2008-present, Member, CDMRP Neurofibromatosis Consortium Membership Committee

2008-present, Member, Adverse Event Monitoring Committee, Pediatric Brain Tumor Consortium

2006-present, Member, Neurofibroma Committee, CDMRP Neurofibromatosis Consortium

2006-present, Member, Visual Pathway Glioma Committee, CDMRP Neurofibromatosis Consortium

2004-present, Member, Children's Oncology Group Late Effects Committee Long-term Follow-up Screening Guidelines Neurologic Complications Task Force

Original Papers

2011

Avery RA, Liu GT, Fisher MJ, Quinn GE, Belasco JB, Phillips PC, et al. Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol. 2011 Mar;151(3):542-9.e2. Epub 2011 Jan 12. Cited in PubMed: PMID 21232732. Read the abstract

2010

Palmer SL, Hassall T, Evankovich K, Mabbott DJ, Bonner M, Deluca C, et al. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro Oncol. 2010 Dec 12(12):1311-7. Epub 2010 Aug 16.Cited in PubMed: PMID 20713408. Read abstract.

2009

Sievert AJ, Fisher MJ. Pediatric low-grade gliomas. J Child Neurol. 2009 Nov;24(11):1397-408. Cited in PubMed: PMID 19841428. Read the article

Packer RJ, Jakacki R, Horn M, Rood B, Vezina G, MacDonald T, et al. Objective response of multiply recurrent pediatric low-grade gliomas to bevacizumab and irinotecan. Pediatric Blood & Cancer, 52:791–795, 2009. Cited in PubMed: PMID 19165892. Read the abstract

Chi SN, Zimmerman MA, Yao X, Fletcher W, Cohen K, Burger P, et al.   Intensive multi-modality treatment for children with newly diagnosed  CNS atypical teratoid rhabdoid tumor. J Clin Oncol, 27(3):385-9, 2009. Epub 2008 Dec 8. Cited in PubMed: PMID 19064966. Read the article

Posters and Presentations

2010

Fisher MJ. NF1 and optic pathway gliomas: an update [presentation]. University Children's Hospital Ljubljana; 2010 Jun 24; Ljubljana, Slovenia.

Fisher MJ. Phase II study of the mTOR inhibitor sirolimus for non-progressive NF1-associated plexiform neurofibromas: a Neurofibromatosis Consortium study [presentation]. 14th International Symposium on Pediatric Neuro-Oncology; 2010 Jun 23; Vienna, Austria.

Fisher MJ. Neurofibromatosis type 1 associated optic glioma visual outcomes following chemotherapy: a multi-center retrospective analysis [presentation]. 2010 Children's Tumor Foundation NF Conference; 2010 Jun 7; Baltimore, MD.

Fisher MJ. Resolved: all NF1 patients should not have whole body MRI to assess the burden of disease at time of diagnosis [presentation]. 2010 Children's Tumor Foundation NF Conference; 2010 Jun 6; Baltimore, MD.

Fisher MJ. A phase II study of the mTOR inhibitor sirolimus for NF1-associated plexiform neurofibromatomas: a Neurofibromatosis Consortium study [presentation]. 2010 Children's Tumor Foundation NF Conference; 2010 Jun 5; Baltimore, MD.

Fisher MJ. Other clinical trials for NF1 [presentation]. 2010 NF Family Conference; 2010 Apr 17; Cincinnati, OH.

Fisher MJ. Clinical trials for plexiform neurofibromatosis [presentation]. 2010 NF Family Conference; 2010 Apr 17; Cincinnati, OH.

Fisher MJ. NF1 and optic pathways gliomas: an update [oncology grand rounds]. Cincinnati Children's Hospital Medical Center; 2010 Apr 16; Cincinnati, OH.

Fisher MJ. Neurofibromatosis type 1 associated optic glioma visual outcomes following chemotherapy: a multi-center retrospective analysis [presentation]. 36th Annual North American Neuro-Ophthalmology Society Meeting; 2010 Mar 8; Tuscon, AZ.

Fisher MJ. Brain tumor 101 [presentation]. Pediatric Brain Tumor Consortium Meeting; 2010 Feb 28; Alexandria, VA.

2009

Fisher MJ. New imaging modalities and treatment approaches for plexiform neurofibromas [presentation]. Shanghai Children's Medical Center; 2009 Nov 6; Shanghai, China.

Fisher MJ. Plexiform neurofibromas: new approaches to management [presentation]. Beijing Children's Hospital; 2009 Nov 3; Beijing, China.

Fisher MJ. Photodynamic therapy in children with NF1 and plexiform neurofibromas [presentation]. 2009 Children's Tumor Foundation NF Conference; 2009 Jun 14; Portland, OR.

Fisher MJ. Vinblastine/methotrexate for plexiform neurofibromas: a phase II study [presentation]. Neurofibromatosis Consortium Meeting; 2009 Jun 13; Portland, OR.

Fisher MJ. Phase I trial of photodynamic therapy (PDT) using intratumoral delivery of non-coherent light for photoactivation of LS11 in children with plexiform neurofibromas [presentation]. Neurofibromatosis Consortium Meeting; 2009 Jun 13; Portland, OR.

 

« Back to Previous Page
  • Print
  • Share

Contact Us